Yamaguchi University School of Medicine, established in 1944 in Ube City, Japan, is part of Yamaguchi University. It is dedicated to the development of medicine and medical treatment, actively engaging in research that utilizes the latest technologies, including AI and big data, as well as advanced medical fields such as genomic medicine, while fostering international collaboration. NEC Labs America collaborates with Yamaguchi University School of Medicine on AI-powered diagnostic support tools, integrating multimodal data to facilitate early intervention. Please read about our latest news and collaborative publications with Yamaguchi University School of Medicine.

Posts

Prediction of Early Recurrence of Hepatocellular Carcinoma after Resection using Digital Pathology Images Assessed by Machine Learning

Hepatocellular carcinoma (HCC) is a representative primary liver cancer caused by long-term and repetitive liver injury. Surgical resection is generally selected as the radical cure treatment. Because the early recurrence of HCC after resection is associated with low overall survival, the prediction of recurrence after resection is clinically important. However, the pathological characteristics of the early recurrence of HCC have not yet been elucidated. We attempted to predict the early recurrence of HCC after resection based on digital pathologic images of hematoxylin and eosin-stained specimens and machine learning applying a support vector machine (SVM). The 158 HCC patients meeting the Milan criteria who underwent surgical resection were included in this study. The patients were categorized into three groups: Group I, patients with HCC recurrence within 1 year after resection (16 for training and 23 for test), Group II, patients with HCC recurrence between 1 and 2 years after resection (22 and 28), and Group III, patients with no HCC recurrence within 4 years after resection (31 and 38). The SVM-based prediction method separated the three groups with 89.9% (80/89) accuracy. Prediction of Groups I was consistent for all cases, while Group II was predicted to be Group III in one case, and Group III was predicted to be Group II in 8 cases. The use of digital pathology and machine learning could be used for highly accurate prediction of HCC recurrence after surgical resection, especially that for early recurrence. Currently, in most cases after HCC resection, regular blood tests and diagnostic imaging are used for follow-up observation, however, the use of digital pathology coupled with machine learning offers potential as a method for objective postoprative follow-up observation.